Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06365047Phase 3Active, not recruiting
A Phase 3 trial of arginine in xerostomia, sponsored by Tufts University. Started Aug 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06365047.